Trials / Unknown
UnknownNCT00192777
Concurrent Xeloda and Radiotherapy for Bone Metastases
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Hypothesis: Radiosensitization using Xeloda should improve the rate of complete pain relief. Primary Objective: * To determine the frequency of pain relief for the proposed regimen. Secondary Objective(s): * To determine the duration of pain relief and narcotic relief for the proposed regimen. * To determine the frequency of narcotic relief for the proposed regimen. * To determine the toxicity of concurrent UFT and radiotherapy in patients with bone metastases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xeloda | |
| PROCEDURE | External Beam Radiotherapy |
Timeline
- Start date
- 2004-11-01
- First posted
- 2005-09-19
- Last updated
- 2007-10-08
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00192777. Inclusion in this directory is not an endorsement.